We also examined RNA expression from a cohort of prostate cancer patient samples in the Grasso data set available on Oncomine49, and found that loss of PTEN expression also coincides with an increase in PTK6 messenger RNA (mRNA) (Fig. 6d). This evidence concerns the gene PTEN and prostate carcinoma.